Weekly Roundup for JUNE 3 2016: Recent Publications in Women’s Mental Health

This week’s highlights include one study looking at the effects of methylphenidate on pregnancy outcomes and an interesting 30-year follow-up study from Myrna Weissman and colleagues on the children of depressed parents.

Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial.

McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Tinker LF, LaCroix AZ.

JAMA Intern Med. 2016 May 23.

REVIEWED ON OUR WEBSITE

Depression, anxiety, and psychotropic medication use and fecundability.

Nillni YI, Wesselink AK, Gradus JL, Hatch EE, Rothman KJ, Mikkelsen EM, Wise LA.

Am J Obstet Gynecol. 2016 Apr 27.

Methylphenidate in pregnancy: a multicenter, prospective, comparative, observational study.

Diav-Citrin O, Shechtman S, Arnon J, Wajnberg R, Borisch C, Beck E, Richardson JL, Bozzo P, Nulman I, Ornoy A.

J Clin Psychiatry. 2016 May 24. [Epub ahead of print]

A review of longitudinal studies on antenatal and postnatal depression.

Underwood L, Waldie K, D’Souza S, Peterson ER, Morton S.

Arch Womens Ment Health. 2016 Apr 16. [Epub ahead of print] Review.

Evaluation and Management of Behavioral Health Disorders in Women: An Overview of Major Depression, Bipolar Disorder, Anxiety Disorders, and Sleep in the Primary Care Setting.

Fitelson E, McGibbon C.

Obstet Gynecol Clin North Am. 2016 Jun;43(2):231-46. Review.

Barriers and Facilitators to the Use of Mental Health Services by Women With Elevated Symptoms of Depression and Their Partners.

Bell L, Feeley N, Hayton B, Zelkowitz P, Tait M, Desindes S.

Issues Ment Health Nurs. 2016 May 18:1-9. [Epub ahead of print]

Offspring of Depressed Parents: 30 Years Later.

Weissman MM, Wickramaratne P, Gameroff MJ, Warner V, Pilowsky D, Kohad RG, Verdeli H, Skipper J, Talati A.

Am J Psychiatry. 2016 Apr 26. [Epub ahead of print]

Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.

Nezvalová-Henriksen K, Spigset O, Brandlistuen RE, Ystrom E, Koren G, Nordeng H.

Int J Epidemiol. 2016 May 17.

Comment: The results indicate that neither maternal depression nor shared genetics and family environment fully explain the association between SSRI exposure and birthweight or gestational age.

Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age.

Viktorin A, Lichtenstein P, Lundholm C, Almqvist C, D’Onofrio BM, Larsson H, Landén M, Magnusson PK.

Int J Epidemiol. 2016 Feb;45(1):170-7. –

Comment: No association between birth weight and ssri exposure

The Effects of Intranasal Oxytocin Administration on Sensitive Caregiving in Mothers with Postnatal Depression.

Mah BL, Van Ijzendoorn MH, Out D, Smith R, Bakermans-Kranenburg MJ.

Child Psychiatry Hum Dev. 2016 Apr 21. [Epub ahead of print]

Comment: Oxytocin had no effect on maternal sensitivity in interactions with her own baby.

Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.

Johnson KC, Smith AK, Stowe ZN, Newport DJ, Brennan PA.

J Clin Psychiatry. 2016 Feb;77(2):e176-82.

Should women of childbearing potential be prescribed valproate? a call to action.